References
Abd El-Razek, M.H., Ohta, S., Ahmed, A.A., and Hirata, T. (2001). Sesquiterpene coumarins from the roots of Ferula assa-foetida.Phytochemistry 58(8), 1289-1295.
Ariumi, Y., Kaida, A., Lin, J.Y., Hirota, M., Masui, O., Yamaoka, S., et al. (2000). HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration.Oncogene 19(12), 1491-1499. doi: 10.1038/sj.onc.1203450.
Arslan, D., Tural, D., and Akar, E. (2013). Herbal administration and interaction of cancer treatment. J Palliat Med 16(11),1466-1476. doi: 10.1089/jpm.2013.0126.
Bartke, T., Siegmund, D., Peters, N., Reichwein, M., Henkler, F., Scheurich, P., et al. (2001). p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene20(5), 571-580. doi: 10.1038/sj.onc.1204124.
Bazarbachi, A., El-Sabban, M.E., Nasr, R., Quignon, F., Awaraji, C., Kersual, J., et al. (1999). Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood93(1), 278-283.
Bazzaz, B.S., Memariani, Z., Khashiarmanesh, Z., Iranshahi, M., and Naderinasab, M. (2010). Effect of galbanic Acid, a sesquiterpene coumarin from ferula szowitsiana, as an inhibitor of efflux mechanism in resistant clinical isolates of Staphylococcus aureus. Braz J Microbiol 41(3), 574-580. doi: 10.1590/s1517-83822010000300006.
Bedniak, A. (1962). On the problem of the isolation of galbanic acid from Ferula gumosa Boiss. roots. Aptechnoe delo 12,28-34.
Bedniak, A.E., Pershin, G.N., and Milovanova, S.N. (1967). [Antibacterial activity of galbanic acid and of its conversion products]. Farmatsiia 16(4), 45-49.
Djerbi, M., Screpanti, V., Catrina, A.I., Bogen, B., Biberfeld, P., and Grandien, A. (1999). The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. Journal of Experimental Medicine 190(7),1025-1032.
Duyao, M., Kessler, D., Spicer, D., Bartholomew, C., Cleveland, J., Siekevitz, M., et al. (1992). Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B.Journal of Biological Chemistry 267(23), 16288-16291.
El-Sabban, M.E., Nasr, R., Dbaibo, G., Hermine, O., Abboushi, N., Quignon, F., et al. (2000). Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. Blood 96(8),2849-2855.
Eskandani, M., Abdolalizadeh, J., Hamishehkar, H., Nazemiyeh, H., and Barar, J. (2015a). Galbanic acid inhibits HIF-1α expression via EGFR/HIF-1α pathway in cancer cells. Fitoterapia 101,1-11.
Eskandani, M., Barar, J., Dolatabadi, J.E., Hamishehkar, H., and Nazemiyeh, H. (2015b). Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles. Pharm Biol 53(10), 1525-1538. doi: 10.3109/13880209.2014.991836.
Haller, K., Ruckes, T., Schmitt, I., Saul, D., Derow, E., and Grassmann, R. (2000). Tax-dependent stimulation of G1 phase-specific cyclin-dependent kinases and increased expression of signal transduction genes characterize HTLV type 1-transformed T cells. AIDS Res Hum Retroviruses 16(16), 1683-1688. doi: 10.1089/08892220050193146.
Hanafi-Bojd, M.Y., Iranshahi, M., Mosaffa, F., Tehrani, S.O., Kalalinia, F., and Behravan, J. (2011). Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. Planta Med77(14), 1590-1593. doi: 10.1055/s-0030-1270987.
Hermine, O., Ramos, J.C., and Tobinai, K. (2018). A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies. Adv Ther 35(2), 135-152. doi: 10.1007/s12325-018-0658-4.
Hironaka, N., Mochida, K., Mori, N., Maeda, M., Yamamoto, N., and Yamaoka, S. (2004). Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia6(3), 266-278. doi: 10.1593/neo.3388.
Horie, R. (2007). NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma. Int Rev Immunol 26(5-6),269-281. doi: 10.1080/08830180701703364.
Iranshahi, M., Arfa, P., Ramezani, M., Jaafari, M.R., Sadeghian, H., Bassarello, C., et al. (2007). Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry68(4), 554-561.
Iranshahi, M., Kalategi, F., Rezaee, R., Shahverdi, A.R., Ito, C., Furukawa, H., et al. (2008). Cancer chemopreventive activity of terpenoid coumarins from Ferula species. Planta Med74(2), 147-150. doi: 10.1055/s-2008-1034293.
Iranshahi, M., Rezaee, R., Najafi, M.N., Haghbin, A., and Kasaian, J. (2018). Cytotoxic activity of the genus Ferula (Apiaceae) and its bioactive constituents. Avicenna journal of phytomedicine8(4), 296.
Iranshahy, M., and Iranshahi, M. (2011). Traditional uses, phytochemistry and pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin)—A review. Journal of ethnopharmacology134(1), 1-10.
Ishitsuka, K., Hanada, S., Suzuki, S., Utsunomiya, A., Chyuman, Y., Takeuchi, S., et al. (1998). Arsenic trioxide inhibits growth of human T‐cell leukaemia virus type I infected T‐cell lines more effectively than retinoic acids. British journal of haematology103(3), 721-728.
Ishitsuka, K., Ikeda, R., Utsunomiya, A., Uozumi, K., Hanada, S., Suzuki, S., et al. (2002). Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.Leuk Lymphoma 43(5), 1107-1114.
Jafari, A., Teymouri, M., Nik, M.E., Abbasi, A., Iranshahi, M., Hanafi-Bojd, M.Y., et al. (2019). Interactive anticancer effect of nanomicellar curcumin and galbanic acid combination therapy with some common chemotherapeutics in colon carcinoma cells. Avicenna journal of phytomedicine 9(3), 237.
Kasaian, J., Iranshahy, M., and Iranshahi, M. (2014). Synthesis, biosynthesis and biological activities of galbanic acid–A review.Pharmaceutical biology 52(4), 524-531.
Kashanchi, F., and Brady, J.N. (2005). Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene24(39), 5938-5951. doi: 10.1038/sj.onc.1208973.
Kchour, G., Rezaee, R., Farid, R., Ghantous, A., Rafatpanah, H., Tarhini, M., et al. (2013). The combination of arsenic, interferon-alpha, and zidovudine restores an ”immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology 10, 91. doi: 10.1186/1742-4690-10-91.
Kchour, G., Tarhini, M., Kooshyar, M.M., El Hajj, H., Wattel, E., Mahmoudi, M., et al. (2009). Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).Blood 113(26), 6528-6532. doi: 10.1182/blood-2009-03-211821.
Kim, K.H., Lee, H.J., Jeong, S.J., Lee, H.J., Lee, E.O., Kim, H.S., et al. (2011). Galbanic acid isolated from Ferula assafoetida exerts in vivo anti-tumor activity in association with anti-angiogenesis and anti-proliferation. Pharm Res 28(3), 597-609. doi: 10.1007/s11095-010-0311-7.
Kim, Y.H., Shin, E.A., Jung, J.H., Park, J.E., Koo, J., Koo, J.I., et al. (2019). Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5. European journal of pharmacology847, 91-96.
Krueger, A., Fas, S.C., Giaisi, M., Bleumink, M., Merling, A., Stumpf, C., et al. (2006). HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).Blood 107(10), 3933-3939. doi: 10.1182/blood-2005-06-2567.
Lau, A., Nightingale, S., Taylor, G.P., Gant, T.W., and Cann, A.J. (1998). Enhanced MDR1 gene expression in human T-cell leukemia virus-I-infected patients offers new prospects for therapy. Blood91(7), 2467-2474.
Mahieux, R., Pise-Masison, C., Gessain, A., Brady, J.N., Olivier, R., Perret, E., et al. (2001). Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood98(13), 3762-3769.
Matsuoka, M., and Jeang, K.-T. (2007). Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nature Reviews Cancer 7(4), 270-280.
Medema, J.P., de Jong, J., van Hall, T., Melief, C.J., and Offringa, R. (1999). Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. Journal of Experimental Medicine190(7), 1033-1038.
Mori, N., Fujii, M., Ikeda, S., Yamada, Y., Tomonaga, M., Ballard, D.W., et al. (1999). Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 93(7), 2360-2368.
Mulloy, J.C., Kislyakova, T., Cereseto, A., Casareto, L., LoMonico, A., Fullen, J., et al. (1998). Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol 72(11), 8852-8860.
Oh, B.S., Shin, E.A., Jung, J.H., Jung, D.B., Kim, B., Shim, B.S., et al. (2015). Apoptotic effect of galbanic acid via activation of caspases and inhibition of Mcl‐1 in H460 non‐small lung carcinoma cells.Phytotherapy Research 29(6), 844-849.
Okamoto, K., Fujisawa, J., Reth, M., and Yonehara, S. (2006). Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.Genes Cells 11(2), 177-191. doi: 10.1111/j.1365-2443.2006.00927.x.
Ozaki, T., and Nakagawara, A. (2011). p53: the attractive tumor suppressor in the cancer research field. J Biomed Biotechnol2011, 603925. doi: 10.1155/2011/603925.
Portis, T., Grossman, W.J., Harding, J.C., Hess, J.L., and Ratner, L. (2001). Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model. J Virol 75(5),2185-2193. doi: 10.1128/jvi.75.5.2185-2193.2001.
Ressler, S., Morris, G.F., and Marriott, S.J. (1997). Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter. J Virol 71(2), 1181-1190.
Romeo, M.M., Ko, B., Kim, J., Brady, R., Heatley, H.C., He, J., et al. (2015). Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC. Virology 476,271-288. doi: 10.1016/j.virol.2014.12.008.
Schmitt, I., Rosin, O., Rohwer, P., Gossen, M., and Grassmann, R. (1998). Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein. J Virol72(1), 633-640.
Sherr, C.J., and Roberts, J.M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9(10), 1149-1163. doi: 10.1101/gad.9.10.1149.
Sun, S.C., and Yamaoka, S. (2005). Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene 24(39),5952-5964. doi: 10.1038/sj.onc.1208969.
Suzuki, T., Kitao, S., Matsushime, H., and Yoshida, M. (1996). HTLV‐1 Tax protein interacts with cyclin‐dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. The EMBO journal 15(7), 1607-1614.
Syrov, V.N., Khushbaktova, Z.A., and Nabiev, A.N. (1990). [The effect of galbanic acid on the course of experimental hepatitis].Farmakol Toksikol 53(2), 41-43.
Tanaka, A., Takahashi, C., Yamaoka, S., Nosaka, T., Maki, M., and Hatanaka, M. (1990). Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proceedings of the National Academy of Sciences 87(3), 1071-1075.
Tsukasaki, K., and Tobinai, K. (2012). Clinical Trials and Treatment of ATL. Leuk Res Treatment 2012, 101754. doi: 10.1155/2012/101754.
Wang, C.Z., Calway, T., and Yuan, C.S. (2012). Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med 40(4),657-669. doi: 10.1142/s0192415x12500498.
Xu-Monette, Z.Y., Medeiros, L.J., Li, Y., Orlowski, R.Z., Andreeff, M., Bueso-Ramos, C.E., et al. (2012). Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. Blood 119(16),3668-3683. doi: 10.1182/blood-2011-11-366062.
Yaqoob, U., and Nawchoo, I.A. (2016). Distribution and taxonomy of Ferula L.—a review. RRJOB 5(3), 15-23.
Yasunami, T., Wang, Y.H., Tsuji, K., Takanashi, M., Yamada, Y., and Motoji, T. (2007). Multidrug resistance protein expression of adult T-cell leukemia/lymphoma. Leuk Res 31(4), 465-470. doi: 10.1016/j.leukres.2006.10.012.
Yoshida, M. (2001). Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol19, 475-496. doi: 10.1146/annurev.immunol.19.1.475.
Zane, L., Yasunaga, J., Mitagami, Y., Yedavalli, V., Tang, S.W., Chen, C.Y., et al. (2012). Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis. Retrovirology 9, 114. doi: 10.1186/1742-4690-9-114.
Zhang, L.-l., Wei, J.-y., Wang, L., and Chen, J.-l. (2017). Human T-cell lymphotropic virus type 1 and its oncogenesis. Acta Pharmacologica Sinica 38(8), 1093.
Zhang, Y., Kim, K.H., Zhang, W., Guo, Y., Kim, S.H., and Lu, J. (2012). Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells. Int J Cancer130(1), 200-212. doi: 10.1002/ijc.25993.
Table 1. Primer and probe sequences and amplicon lengths